IZERE Salomon

Mr. IZERE Salomon

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2024 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
KMKhaled Moghib
Khaled Moghib
TGThoria I. Ghanm
Thoria I. Ghanm
AAAbdallah Abunamoos
Abdallah Abunamoos
MRMunia Rajabi
Munia Rajabi
SMShehab M. Moawad
Shehab M. Moawad
AAAhmed Amer
Ahmed Amer
Preeclampsia is a severe pregnancy complication affecting 2–8% of pregnancies globally, contributing to substantial maternal and fetal morbidity and mortality. Vitamin D deficiency has been associated with an increased risk of preeclampsia, yet the efficacy of its supplementation during pregnancy in reducing preeclampsia incidence remains uncertain. This systematic review and meta-analysis aimed to evaluate the impact of vitamin D supplementation on the incidence of preeclampsia and related maternal and neonatal outcomes. We systematically searched PubMed, Scopus, Cochrane Library, and Web of Science until August 2024 for randomized controlled trials (RCTs) examining the effects of vitamin D supplementation on preeclampsia. Eligible studies included pregnant women with varying doses of vitamin D supplementation compared to placebo or standard care. Primary outcomes were the incidence of pre-eclampsia and preterm labor; secondary outcomes included serum 25-hydroxyvitamin D levels, low birth weight, and APGAR scores. Data were synthesized using R statistical software, with effect measures reported as relative risk (RR) and mean difference (MD) with a 95% confidence interval (CI). A total of 33 RCTs involving 10,613 participants were included. Vitamin D supplementation significantly reduced the risk of preeclampsia by 44.8% (RR = 0.55, 95% CI [0.43, 0.71], P < 0.0001) and preterm labor by 30% (RR = 0.70, 95% CI [0.51, 0.96], P = 0.0286). Subgroup analyses indicated that the benefits were more pronounced when the control group received a placebo rather than low-dose vitamin D. Serum 25-hydroxyvitamin D levels significantly increased in the supplementation group (MD = 32.42 nmol/L, 95% CI [20.33, 44.50], P < 0.0001). However, no significant differences were observed in the incidence of low birth weight (RR = 0.65, 95% CI [0.42, 1.02], P = 0.057) or Apgar scores at 5 min (MD = 0.20, 95% CI [-0.01, 0.40], P = 0.057). Vitamin D supplementation during pregnancy significantly reduces the risk of preeclampsia and preterm labor, though its impact on neonatal outcomes remains unclear. These findings underscore the potential value of vitamin D supplementation in prenatal care for improving maternal outcomes. Further research is needed to clarify its effects on neonatal health.

8 October 2024 in Brain and Behavior
Verified
Journal Article
Open access
ISIZERE Salomon
IZERE Salomon
Background: Cerebral palsy (CP) is a common neurodevelopmental disorder characterized by impaired mobility and posture caused by brain injury or abnormal development. CP relates to a variety of neurological mechanisms and pathways that impact the type and severity of motor disability, as well as comorbidities. The heterogeneity in clinical phenotype, pathogenesis, and etiology poses significant challenges for effective therapeutic intervention.Objectives: The review aims to provide a comprehensive analysis of the neurobiological mechanisms underlying CP and evaluate current and prospective therapeutic strategies, highlighting the necessity for targeted interventions to address the disorder's multifaceted nature.Methods: A thorough literature review was conducted, focusing on studies published in peer‐reviewed journals that explore the pathophysiological mechanisms, clinical interventions, and therapeutic strategies for CP.Results: The pathogenesis of CP involves a complex interplay of genetic, environmental, and perinatal factors leading to brain injury. Inflammatory processes, oxidative stress, and excitotoxicity are critical in CP development. Current therapeutic approaches primarily focus on symptom management through physical and occupational therapy, as well as pharmacological interventions. Emerging therapies, including anti‐inflammatory agents, antioxidants, and neuroprotective and neurotrophic agents, show potential but require further validation. Notably, although steroids provide anti‐inflammatory benefits, their use in pediatric patients raises concerns regarding long‐term adverse effects such as osteoporosis.Conclusion: Despite advances in understanding CP's neurobiological underpinnings, effective therapeutic targets remain elusive. A comprehensive approach addressing CP's heterogeneity is essential. Future research should emphasize in‐depth evaluations of the efficacy and safety of therapeutic agents, particularly in pediatric populations, to develop targeted and effective treatments for CP.

4 June 2024 in International Journal of Surgery Open
Verified
Journal Article
Open access
ISIZERE Salomon
IZERE Salomon
SOSibomana Mbbs Olivier
Sibomana Mbbs Olivier
The term ‘artificial intelligence’ (AI) is used to describe the application of computers and technology to mimic human problem solving and creativity. The possibility of AI in medicine is rapidly evolving and its utility in clinical practice may soon become commonplace. The application of AI in medicine has been considered an opportunity to advance medicine as it helps to store, analyze, and interpret large amounts of data and lead to increased diagnostic accuracy, speed, and optimize treatment strategies. On the other hand, many physicians are concerned that AI will replace medical professionals and lead to the ‘dehumanization’ of medicine. In medicine, the evolution of AI promises better outcomes through more efficient diagnosis and accuracy of individualized treatments. As such, appropriate regulatory policies must be explored to ensure the safe implementation of AI in medicine to avoid losing the humanistic art of medical practice. The aim of this correspondence is to shed light on the AI in medicine, advantages, and their disadvantages in this today and future medical field.

1 June 2024 in Hepatic Medicine: Evidence and Research
Verified
Journal Article
Open access
PDF file
ISIZERE Salomon
IZERE Salomon
SOSibomana Olivier
Sibomana Olivier
NENdayambaje Egide
Ndayambaje Egide
The hepatitis C virus (HCV) poses a significant risk to global public health and is linked to life-threatening clinical outcomes. According to the WHO, there are an estimated 58 million people worldwide who have a chronic hepatitis C virus (HCV) infection; there are 1.5 million new cases and more than 350,000 fatalities from HCV-related illnesses each year. Even though there are numerous diagnostic techniques, the lack of funding, inadequate healthcare infrastructure, and low public awareness of the Hepatitis C virus can make diagnosis and treatment difficult to obtain throughout the continent. The frequency of hepatitis C virus infection is highest in African nations (1– 26%), raising serious concerns about the virus’s impact on public health. The world’s highest rate of Hepatitis C virus infection was found in Egypt, an African nation. Its nationwide hepatitis C elimination program stands out as a prime example of achievement, having screened, and treated over 60 million people, significantly reducing the disease’s incidence and prevalence. Other African nations facing similar difficulties might benefit greatly from Egypt’s methods, which provide valuable insights and flexible frameworks. This review aims to shed light on Egypt’s successes and challenges while offering strategic recommendations to African nations to quicken their progress in eliminating hepatitis C.

1 January 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
HAHuda Mbbs Adnan
Huda Mbbs Adnan
ISIZERE Salomon
IZERE Salomon
MAMaryam Mbbs Ahmed
Maryam Mbbs Ahmed

16 December 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
ISIZERE Salomon
IZERE Salomon
AHAli Emir Hamitoglu
Ali Emir Hamitoglu
UHUnkwiye Hertier
Unkwiye Hertier
MBMugabekazi Albright Belise
Mugabekazi Albright Belise
USUwase Sandrine
Uwase Sandrine
MAMethode Yusufu Abdoulkarim
Methode Yusufu Abdoulkarim
Background: The Monkeypox virus (MPXV), a member of the Orthopoxvirus genus, is responsible for the zoonotic disease known as MPX. Primarily found in western and central Africa, emerging studies indicate a shift in transmission dynamics. Ongoing MPX outbreaks in the Democratic Republic of Congo (DRC) have escalated into significant public health concerns.Objectives: This review endeavors to provide a comprehensive analysis of the public health implications, clinical consequences, and preventive measures related to the current MPX outbreak in the DRC. It focuses on the epidemiology, clinical manifestations, and public health responses to this global health challenge.Methodology: The research synthesizes data regarding MPX outbreaks in the DRC, drawing from academic journals, public health reports, and case studies through a narrative review approach.Results: The recent outbreak in the DRC has identified approximately 12,569 suspected MPX cases, resulting in 581 fatalities, which corresponds to a case fatality rate (CFR) of 4.6%. These cases have been documented across 156 health sectors in 22 out of 26 provinces, representing the highest case count recorded to date. The epidemic has also encroached upon previously unaffected regions. Hospitalization rates have varied between 4% and 10%, with a significant percentage of cases attributed to sexual transmission. Analysis of demographic and geographic data revealed distinct patterns in viral spread. Clinical outcomes have varied, with an average CFR close to 10%, influenced by factors such as timely diagnosis and access to healthcare services. Rural areas have accounted for over 70% of the cases, highlighting the necessity for targeted public health interventions. Control measures have focused on community awareness campaigns and immunization programs, reaching approximately 50% of the at‐risk population; however, challenges related to resource limitations and political instability have impeded effective response strategies.Conclusion: The ongoing MPX outbreak in the DRC poses a substantial public health challenge. While progress has been made in managing the epidemic, it remains imperative to address resource deficiencies and enhance public health systems. Strengthening international collaboration, expanding healthcare access, and improving surveillance capabilities are critical to mitigating the risk of future outbreaks.